PHILADELPHIA -- Any beta-blocker use was associated with a higher risk of postoperative stroke, according to research that also found that these medications may factor into racial disparities in ...

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers. Using clinical information from a large, ...

LONDON, England—In a somewhat surprising finding, a randomized trial has shown that stopping beta-blockers in patients with a history of myocardial infarction might be harmful when compared with ...

The accepted clinical practice of using beta blockers over the long term to curb the risk of further heart attacks or death doesn’t seem to be warranted in patients who don’t have heart failure, ...

What recommendations would you offer to clinicians regarding shared decision-making with patients regarding this issue? Dr Granger: Based on the REDUCE-AMI trial results, I would recommend that ...

Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...

Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD), according to a new study. A common heart drug may slow the ...

Please provide your email address to receive an email when new articles are posted on . Use of beta-blockers was associated with a reduced likelihood of patients undergoing TKA for OA. Use of ...

Patients (N = 4,192) younger than 65 years with HNSCC, NSCLC, melanoma, or skin SCC treated at MD Anderson Cancer Center from 2010 to 2021 were included. Overall survival (OS), disease-specific ...